Actively Recruiting
Investigation of Three Biomarkers for the Detection of Prostate Cancer
Led by Medtechtomarket Consulting Ltd · Updated on 2025-01-17
137
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
Sponsors
M
Medtechtomarket Consulting Ltd
Lead Sponsor
G
GlycoscoreDx Ltd
Collaborating Sponsor
AI-Summary
What this Trial Is About
GlycoScore Dx Limited, a diagnostics company based in the United Kingdom have identified three glycoproteins, that showed promise as biomarkers of prostate cancer in initial validation studies. The purpose of this study is to further evaluate the sensitivity and specificity of the GlycoScore biomarkers for the detection of clinically significant prostate cancer. Sensitivity and specificity will be determined for each marker, combinations of the three markers and combinations of the GlycoScore biomarkers with PSA (prostate specific antigen). The results from this study will be used to identify the most suitable biomarker/biomarkers for use in developing a GlycoScore test. This is a prospective, non-interventional study using venous blood samples taken from patients with suspected prostate cancer or on active surveillance, attending the hospital Urology department for a transperineal biopsy.
CONDITIONS
Official Title
Investigation of Three Biomarkers for the Detection of Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients aged 18 years and over
- Patients being investigated for suspected prostate cancer or on active surveillance
- Patients able to give consent to participate in the study
You will not qualify if you...
- Patients who have already taken part in the study
- Patients with an active urinary tract infection
- Patients with a prior diagnosis of any other cancer or receiving any cancer treatment, including ADT
- Patients currently or within the last 4 months enrolled in another study involving an investigational medicinal product
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Royal Liverpool University Hospital
Liverpool, United Kingdom, L7 8XP
Actively Recruiting
Research Team
R
Rebecca Newman, BSc
CONTACT
L
Lindsay Traynor, BSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here